Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Public consultation (MLX 350): Amendments to the Medicines for Human Use (Marketing Authorisations, etc.) Regulations 1994 to clarify pharmacovigilance reporting requirements

Document details:

Type: Publication
Series No: 350
Audience: Healthcare Professionals
Published: 23 May 2008
Format: Electronic and Paper
Size: A4
Pages: 30
Price: Free
ISBN/ISSN: n/a
Author: MHRA
Copyright: Crown
   

Related information:

MLX350 seeks your views on amendments to the Medicines for Human Use (Marketing Authorisations, etc.) Regulations 1994 to clarify pharmacovigilance reporting requirements.

The deadline for response is 15 August 2008.

Responses should be sent to Mr Stephen Fawbert at the address below:

Stephen Fawbert
Medicines and Healthcare products Regulatory Agency
Room 14-110
Market Towers
1 Nine Elms Lane
London
SW8 5NQ

Tel: 0207 084 2788
Fax: 0207 084 2293
Email: stephen.fawbert@mhra.gsi.gov.uk

Online response form for MLX 350

A summary of the responses will be published on the MHRA website, together with an update on implementation.

 

Page last modified: 23 May 2008